Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Naive Patients”

771 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 771 results

Early research (Phase 1)Study completedNCT02217904
What this trial is testing

Islatravir (MK-8591) in Anti-Retroviral Therapy-Naive, Human Immunodeficiency Virus-1 Infected Participants (MK-8591-003)

Who this might be right for
HIV-1
Merck Sharp & Dohme LLC 30
Not applicableStudy completedNCT03377855
What this trial is testing

Addressing Origins of the Opioid Epidemic by Improving Prescribing for Opioid-Naive Patients

Who this might be right for
Opioid UseOpioid-Related DisordersOpioid Abuse+1 more
Weill Medical College of Cornell University 948
Not applicableStudy completedNCT01541085
What this trial is testing

An Immunologic Study of Treatment-Naive HIV Patients Starting a Darunavir/Ritonavir- or Efavirenz-Based HAART

Who this might be right for
Human Immunodeficiency Virus; HIV
Janssen-Cilag S.p.A. 33
Not applicableStudy completedNCT04752748
What this trial is testing

Power Doppler in Hand Joints of Early RA Patients

Who this might be right for
Early Rheumatoid Arthritis
Federal University of São Paulo 48
Not applicableUnknownNCT03683485
What this trial is testing

Long-duration EPBD vs EST for Removal of Biliary Stones

Who this might be right for
Cholangiopancreatography, Endoscopic Retrograde
Dankook University 358
Testing effectiveness (Phase 2)Study completedNCT00002235
What this trial is testing

A Study on the Safety and Effectiveness of Twice-Daily Nelfinavir Plus Twice-Daily Indinavir Plus Efavirenz in HIV-Positive Patients Who Have Never Taken Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) or Protease Inhibitors

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 6
Large-scale testing (Phase 3)UnknownNCT00536848
What this trial is testing

The Effect of Probiotics on the Immune Status, Diarrhea and Bacterial Vaginosis Cure Rate Among HIV Patients

Who this might be right for
HIV InfectionsDiarrheaBacterial Vaginosis
National Institute for Medical Research, Tanzania 65
Large-scale testing (Phase 3)Study completedNCT01492426
What this trial is testing

Study Comparing Daclatasvir (BMS-790052) With Telaprevir Combined With Peginterferon Alfa-2a and Ribavirin in Patients With Chronic Hepatitis C Virus Infection

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 605
Post-approval studies (Phase 4)Study completedNCT01196078
What this trial is testing

Tarceva (Erlotinib) in Elderly Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Hoffmann-La Roche 114
Early research (Phase 1)Study completedNCT00313508
What this trial is testing

Dendritic Cell Vaccination During Lymphoid Reconstruction

Who this might be right for
Intraocular MelanomaMelanoma (Skin)
H. Lee Moffitt Cancer Center and Research Institute 18
Testing effectiveness (Phase 2)WithdrawnNCT04495010
What this trial is testing

Neoadjuvant Nivolumab+Ipilimumab Followed by Adjuvant Nivolumab or Neoadjuvant Nivolumab+Ipilimumab Followed by Adjuvant Observation Compared With Adjuvant Nivolumab in Treatment-Naive High-risk Melanoma Participants

Who this might be right for
Melanoma
Bristol-Myers Squibb
Large-scale testing (Phase 3)Study completedNCT00143455
What this trial is testing

Study Of Irinotecan Hydrochloride (Campto(R)) And Cisplatin Versus Etoposide And Cisplatin In Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Carcinoma
Pfizer 485
Testing effectiveness (Phase 2)Study completedNCT00822315
What this trial is testing

Efficacy and Safety of 2 Raltegravir Doses in Naive HIV-1-infected Patients Receiving Rifampin for Active Tuberculosis

Who this might be right for
HIV InfectionsTuberculosis
ANRS, Emerging Infectious Diseases 155
Post-approval studies (Phase 4)Ended earlyNCT00122668
What this trial is testing

Evaluation of the Occurrence of Lipoatrophy in HIV-1 Infected Naive Patients

Who this might be right for
HIV InfectionsHIV-Associated Lipodystrophy Syndrome
French National Agency for Research on AIDS and Viral Hepatitis 112
Testing effectiveness (Phase 2)Ended earlyNCT00544674
What this trial is testing

PR104 in Treating Patients With Previously Untreated or Relapsed Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Proacta, Incorporated 5
Testing effectiveness (Phase 2)Ended earlyNCT00299390
What this trial is testing

Safety and Efficacy Study of a New Chemotherapy Agent to Treat Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Carcinoma
Bayer 10
Post-approval studies (Phase 4)Study completedNCT00192595
What this trial is testing

Tenofovir in HIV/HBV Coinfection

Who this might be right for
HIV InfectionHepatitis B Coinfection
Kirby Institute 36
Testing effectiveness (Phase 2)Study completedNCT00002413
What this trial is testing

MKC-442 in HIV-Positive Patients

Who this might be right for
HIV Infections
Triangle Pharmaceuticals
Large-scale testing (Phase 3)Study completedNCT00381342
What this trial is testing

Safety and Efficacy of Exenatide as Monotherapy

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 233
Post-approval studies (Phase 4)Study completedNCT04549597
What this trial is testing

Study to Evaluate the Use of Tenapanor as Core Therapy in the Treatment of Hyperphosphatemia

Who this might be right for
Chronic Kidney Disease Requiring Chronic DialysisHyperphosphatemia
Ardelyx 333
Next Page